As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

mnfr1908-sup-0001-FigureS1.doc43KFigure S1. Effect of CDCQ on LXRα mRNA expression in HepG2 cells. HepG2 cells were grown in serum-free medium overnight and incubated in DMEM containing normal (5.5 mM) or high (30 mM) glucose concentrations in the absence or presence of CDCQ (5, 10 μM) or 1 μM T0901317 (a LXRα agonist) for an additional 24 h. Total RNA was extracted and the LXRα mRNA expression was measured by qRT-PCR. The results are expressed as means ± S.E.M. of three independent experiments. #p < 0.01, compared to control. *p < 0.01, compared to high glucose-treated cells.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.